Nor Metanephrines

Elevated normetanephrine means increased breakdown of norepinephrine, often indicating excess catecholamine production such as from a pheochromocytoma or paraganglioma. It can also rise from stress, certain medications (e.g., antidepressants, stimulants), recent exercise, illness, or kidney dysfunction. Elevated levels warrant repeat testing, medication review and further evaluation (imaging and specialist referral) to confirm cause and guide treatment.

Normal metanephrine levels vary by laboratory and test method. Typical cutoffs: plasma free metanephrine <0.5 nmol/L and normetanephrine <0.9 nmol/L; 24‑hour urinary total metanephrines usually <1.0 mg/24 h (≈900 µg/24 h). Results above these ranges need repeat testing and clinical evaluation, since posture, medications and lab methods affect values.

The metanephrines test measures breakdown products of catecholamines (metanephrine and normetanephrine) in blood or urine to detect and monitor catecholamine-secreting tumours such as pheochromocytoma and paraganglioma. It’s used for unexplained high blood pressure, episodic headaches, palpitations or sweating, and to evaluate treatment response or recurrence, guiding imaging and surgical planning.

Normetanephrine is an inactive metabolite of norepinephrine formed by catechol‑O‑methyltransferase. It reflects norepinephrine turnover and sympathetic nervous system activity, and is measured in blood or urine as a diagnostic marker for catecholamine‑secreting tumors (pheochromocytoma/paraganglioma) or to assess dysregulated catecholamine metabolism, and helps guide treatment and follow‑up when elevated. It does not exert significant adrenergic effects itself.

Yes. Metanephrines (metanephrine and normetanephrine) are biochemical tumor markers used to detect catecholamine-secreting tumors such as pheochromocytoma and paraganglioma. Plasma free or 24‑hour urinary fractionated metanephrines are measured; elevated levels strongly suggest these tumors but can produce false positives from certain medications, stress, or other conditions. Positive results usually prompt imaging and further evaluation.

To tell if an adrenal tumor is cancerous, doctors use imaging (CT/MRI, PET) looking for size (>4 cm), irregular margins, local invasion or metastases and suspicious CT characteristics. Hormonal blood/urine tests check for excess cortisol, aldosterone or catecholamines. Rapid growth on serial scans raises concern. Biopsy is rarely used; definitive diagnosis requires histopathology after surgical removal.